FindTrial
Sign In

Evaluating the predictive and diagnostic value of biological markers in complications and patient prognosis after allogeneic hematopoietic stem cell transplantation

Evaluating the predictive and diagnostic value of biological markers in complications and patient prognosis after allogeneic hematopoietic stem cell transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079608
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications after allogeneic hematopoietic stem cell transplantation

Interventions

Allogeneic Hematopoietic Stem Cell Transplantation Patient Group :Allogeneic Hematopoietic Stem Cell Transplantation
Health Checkup Population Group :Health Checkup

Sponsors

the first affiliated hospital of USTC
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1: Patients aged 1-70 years with malignant or non-malignant hematologic diseases who underwent their first allogeneic hematopoietic stem cell transplantation in our department 2: Healthy people undergoing medical checkups at our Health Screening Center

Exclusion criteria

Exclusion criteria: 1: Patients with previous hematopoietic stem cell transplantation history 2: Patients undergoing autologous hematopoietic stem cell transplantation

Design outcomes

Primary

MeasureTime frame
aGVHD;—

Secondary

MeasureTime frame
poor graft function ;cGVHD;primary graft failure ;PES;infection;relapse;acute liver injury ;acute renal injury ;lung injury;TRM;OS;DFS;GRFS;—

Countries

China

Contacts

Public ContactXiaoyu Zhu

the first affiliated hospital of USTC

xiaoyuz@ustc.edu.cn+86 152 5545 6091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026